The U.S. Food and Drug Administration announced that it intends to classify software used to prognostically assess mild cognitive impairment as a Class II medical device, subject to special controls. The agency…
The U.S. Food and Drug Administration announced that it intends to place a wearable vibration device intended for orthopedic applications into the Class II regulatory category, applying special controls specific to this…
According to the provided article, the U.S. Food and Drug Administration is in the process of classifying a digital cervical cytology slide imaging system that incorporates an artificial‑intelligence algorithm as a…
The U.S. Food and Drug Administration announced that it intends to place the external mechanical stimulator used to alleviate nasal congestion into Class II, subject to specific special controls. The agency cited the…
The U.S. Food and Drug Administration announced that a system designed to detect nucleic acid from non‑viral microorganisms that cause sexually transmitted infections, when used with home‑collected specimens, will be…
The U.S. Food and Drug Administration is proposing to place infant pulse rate and oxygen saturation monitors that are sold over the counter into Class II, subject to special controls. The agency has identified a set of…
The U.S. Food and Drug Administration is moving to place a high‑throughput DNA sequencing system used to assess hereditary cancer predisposition into Class II, meaning it will be subject to special controls. The agency…
The U.S. Food and Drug Administration announced a final order that exempts specific class II clinical toxicology test systems from the premarket notification (510(k)) requirement, effective immediately, subject to…
The U.S. Food and Drug Administration announced that it intends to place the hyperoxia monitoring device used alongside pulse oximetry into the Class II regulatory category, applying specific special controls. The…
According to the supplied article, the U.S. Food and Drug Administration is moving to place the focused ultrasound system designed for non‑thermal, mechanical tissue ablation into Class II, subject to a set of special…
The U.S. Food and Drug Administration has announced a proposal to classify the flushing and storage solution used for vascular autografts kept at room temperature as a Class II medical device, subject to specific…